BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 9708367)

  • 1. Terminal Mono- and Bis-Conjugates of Oligonucleotides with
    Novopashina DS; Vorobyeva MA; Lomzov AA; Silnikov VN; Venyaminova AG
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified internucleoside linkages for nuclease-resistant oligonucleotides.
    Clavé G; Reverte M; Vasseur JJ; Smietana M
    RSC Chem Biol; 2021 Feb; 2(1):94-150. PubMed ID: 34458777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in the Synthesis of High Boron-Loaded Nucleic Acids for BNCT.
    Novopashina DS; Vorobyeva MA; Venyaminova A
    Front Chem; 2021; 9():619052. PubMed ID: 33791278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligonucleoside boranophosphate (borane phosphonate).
    Shaw BR; Madison J; Sood A; Spielvogel BF
    Methods Mol Biol; 1993; 20():225-43. PubMed ID: 8242139
    [No Abstract]   [Full Text] [Related]  

  • 5. Carboranyl oligonucleotides. 3. Biochemical properties of oligonucleotides containing 5-(o-carboranyl-1-yl)-2'-deoxyuridine.
    Lesnikowski ZJ; Fulcrand G; Lloyd RM; Juodawlkis A; Schinazi RF
    Biochemistry; 1996 May; 35(18):5741-6. PubMed ID: 8639534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboranyl oligonucleotides: 4. synthesis and physicochemical studies of oligonucleotides containing 2'-O-(o-carboran-1-yl)methyl group.
    Olejniczak AB; Koziolkiewicz M; Lesnikowski ZJ
    Antisense Nucleic Acid Drug Dev; 2002 Apr; 12(2):79-94. PubMed ID: 12074368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approach to incorporation of boron in tumor-seeking molecules.
    Sivaev IB; Semioshkin AA; Bregadze VI
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S91-3. PubMed ID: 19375335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boron containing oligonucleotides.
    Schinazi RF; Lesnikowski ZJ
    Nucleosides Nucleotides; 1998; 17(1-3):635-47. PubMed ID: 9708367
    [No Abstract]   [Full Text] [Related]  

  • 9. Boronated DNA-binding compounds as potential agents for boron neutron capture therapy.
    Crossley EL; Ziolkowski EJ; Coderre JA; Rendina LM
    Mini Rev Med Chem; 2007 Mar; 7(3):303-13. PubMed ID: 17346220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemistry and biology of some low molecular weight boron compounds for boron neutron capture therapy.
    Sjöberg S; Carlsson J; Ghaneolhosseini H; Gedda L; Hartman T; Malmquist J; Naeslund C; Olsson P; Tjarks W
    J Neurooncol; 1997 May; 33(1-2):41-52. PubMed ID: 9151222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications and perspectives of boron-enriched nanocomposites in cancer therapy.
    Yinghuai Z; Hosmane NS
    Future Med Chem; 2013 Apr; 5(6):705-14. PubMed ID: 23617432
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.